Atritech Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 27

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $373M

Atritech General Information

Description

Developer of minimally invasive technologies designed for the prevention of atrial fibrillation related stroke and related diseases. The company's proprietary product WATCHMAN, offers left atrial appendage system, which is designed to prevent harmful sized blood clots formed in the left atrial appendage from entering into blood streams that causes strokes or other complications thus, enabling on improving the quality of life for patients with atrial fibrillation (AF) by providing a permanent alternative to medications that help reduce the risk of AF related stroke.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Acquirer
Boston Scientific
Corporate Office
  • 3750 Annapolis Lane
  • Suite 105
  • Plymouth, MN 55447
  • United States
+1 (763) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Atritech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 03-Mar-2011 $373M 000.00 00000 Completed Generating Revenue
6. Later Stage VC (Series E) 07-Apr-2009 0000 000.00 00000 Completed Generating Revenue
5. Later Stage VC (Series D) 05-Sep-2007 0000 000.00 00000 Completed Generating Revenue
4. Later Stage VC (Series C) 08-Mar-2006 0000 000.00 000.00 Completed Generating Revenue
3. Later Stage VC 26-Jun-2005 00.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) 11-Sep-2003 $10.2M $17.2M 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) $7M $7M 000.00 Completed Generating Revenue
To view Atritech’s complete valuation and funding history, request access »

Atritech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series D 00,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series C 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B 8,123,560 $0.010000 8% $1.25 $1.25 1x $1.25 8.83%
Series A 5,600,000 $0.010000 8% $1.25 $1.25 1x $1.25 6.09%
To view Atritech’s complete cap table history, request access »

Atritech Patents

Atritech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-9913652-B2 Device and method for occluding the left atrial appendage Active 25-Aug-2009 000000000000 00
US-20160066922-A1 Device and method for occluding the left atrial appendage Active 25-Aug-2009 000000000000 0
US-20180070950-A1 Apparatus for delivering an implant without bias to a left atrial appendage Active 01-Dec-2005 000000000000
US-10898198-B2 Apparatus for delivering an implant without bias to a left atrial appendage Active 01-Dec-2005 000000000000 000
US-20150327979-A1 Method and apparatus for recapturing an implant from the left atrial appendage Inactive 01-Dec-2005 A61F2/013 0
To view Atritech’s complete patent history, request access »

Atritech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Atritech Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Affinity Capital Management Venture Capital Minority 000 0000 000000 0
BioStar Capital Venture Capital Minority 000 0000 000000 0
Cressey & Company PE/Buyout Minority 000 0000 000000 0
Edwards Lifesciences Corporation Minority 000 0000 000000 0
Prism Venture Management Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »

Atritech FAQs

  • When was Atritech founded?

    Atritech was founded in 2000.

  • Where is Atritech headquartered?

    Atritech is headquartered in Plymouth, MN.

  • What is the size of Atritech?

    Atritech has 27 total employees.

  • What industry is Atritech in?

    Atritech’s primary industry is Therapeutic Devices.

  • Is Atritech a private or public company?

    Atritech is a Private company.

  • What is the current valuation of Atritech?

    The current valuation of Atritech is 00000.

  • What is Atritech’s current revenue?

    The current revenue for Atritech is 00000.

  • How much funding has Atritech raised over time?

    Atritech has raised $97.6M.

  • Who are Atritech’s investors?

    Affinity Capital Management, BioStar Capital, Cressey & Company, Edwards Lifesciences, and Prism Venture Management are 5 of 11 investors who have invested in Atritech.

  • When was Atritech acquired?

    Atritech was acquired on 03-Mar-2011.

  • Who acquired Atritech?

    Atritech was acquired by Boston Scientific.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »